1
Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
Condition(s):Biliary Tract CancerLast Updated:August 12, 2010Unknown status
Ampullary Adenocarcinoma: 15 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma
Condition(s):Ampullary AdenocarcinomaLast Updated:November 6, 2020Recruiting
3
Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma
Condition(s):Ampulla of Vater Adenocarcinoma; Small Intestinal Adenocarcinoma; Stage III Ampulla of Vater Cancer AJCC v8; Stage III Small Intestinal Adenocarcinoma AJCC v8; Stage IIIA Ampulla of Vater Cancer AJCC v8; Stage IIIA Small Intestinal Adenocarcinoma AJCC v8; Stage IIIB Ampulla of Vater Cancer AJCC v8; Stage IIIB Small Intestinal Adenocarcinoma AJCC v8; Stage IV Ampulla of Vater Cancer AJCC v8; Stage IV Small Intestinal Adenocarcinoma AJCC v8Last Updated:September 3, 2020Completed
4
Recurrence After Whipple’s (RAW) Study: Investigating Recurrence Patterns After Pancreaticoduodenectomy for Pancreatic, Ampullary or Distal Bile Duct Cancer
Condition(s):Pancreatic Cancer; Ampullary Cancer; Bile Duct Cancer; Cholangiocarcinoma, Extrahepatic; Cholangiocarcinoma Resectable; Cholangiocarcinoma of the Extrahepatic Bile Duct; Pancreatic Ductal Adenocarcinoma; Pancreatic Ductal Carcinoma; Surgery; Survivorship; Recurrent Cancer; Cancer Recurrent; Cancer Recurrence; Local Recurrence of Malignant Tumor of PancreasLast Updated:January 7, 2021Recruiting
5
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors
Condition(s):Pancreatic Adenocarcinoma; Pancreatic Cysts; Pancreatic Endocrine Tumors; Chronic Pancreatitis; Cholangiocarcinoma, Extrahepatic; Ampullary Adenocarcinoma; Duodenal AdenocarcinomaLast Updated:May 22, 2020Recruiting
6
ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery
Condition(s):Ampulla of Vater Adenocarcinoma; Gallbladder Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Pancreatic Adenocarcinoma; Stage III Ampulla of Vater Cancer; Stage III Intrahepatic Cholangiocarcinoma; Stage III Pancreatic Cancer; Stage IIIA Gallbladder Cancer; Stage IIIA Hilar Cholangiocarcinoma; Stage IIIB Gallbladder Cancer; Stage IIIB Hilar Cholangiocarcinoma; Stage IV Ampulla of Vater Cancer; Stage IVA Gallbladder Cancer; Stage IVA Hilar Cholangiocarcinoma; Stage IVA Intrahepatic Cholangiocarcinoma; Stage IVA Pancreatic Cancer; Stage IVB Gallbladder Cancer; Stage IVB Hilar Cholangiocarcinoma; Stage IVB Intrahepatic Cholangiocarcinoma; Stage IVB Pancreatic CancerLast Updated:January 30, 2018Completed
7
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Condition(s):Acinar Cell Carcinoma; Ampulla of Vater Adenocarcinoma; Cholangiocarcinoma; Duodenal Adenocarcinoma; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type; Periampullary AdenocarcinomaLast Updated:October 22, 2020Recruiting
8
Endoscopic Papillectomy for Early Ampullary Tumors: Long-term Results of the First Large Multicenter Prospective Study
Condition(s):Ampullary TumorsLast Updated:March 12, 2013Completed
9
Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma
Condition(s):Pancreatic Neoplasms; Adenocarcinoma; Neoplasm Circulating Cells; Tumor Markers, Biological; Monitoring, ImmunologicLast Updated:July 8, 2009Completed
10
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors
Condition(s):Neoplasms; Pancreatic NeoplasmsLast Updated:September 9, 2020Active, not recruiting